搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Burkholderia mallei 50S ribosomal protein L7/L12 (rplL) CSB-YP717309BNS
CSB-EP717309BNS
CSB-BP717309BNS
CSB-MP717309BNS
CSB-EP717309BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 30S ribosomal protein S3 (rpsC) CSB-YP717310BNS
CSB-EP717310BNS
CSB-BP717310BNS
CSB-MP717310BNS
CSB-EP717310BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 50S ribosomal protein L14 (rplN) CSB-YP717311BNS
CSB-EP717311BNS
CSB-BP717311BNS
CSB-MP717311BNS
CSB-EP717311BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 30S ribosomal protein S5 (rpsE) CSB-YP717312BNS
CSB-EP717312BNS
CSB-BP717312BNS
CSB-MP717312BNS
CSB-EP717312BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 30S ribosomal protein S13 (rpsM) CSB-YP717313BNS
CSB-EP717313BNS
CSB-BP717313BNS
CSB-MP717313BNS
CSB-EP717313BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase (coq7) CSB-YP717314BNS
CSB-EP717314BNS
CSB-BP717314BNS
CSB-MP717314BNS
CSB-EP717314BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD), partial CSB-YP717315BNS
CSB-EP717315BNS
CSB-BP717315BNS
CSB-MP717315BNS
CSB-EP717315BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Probable allantoicase 2 (alc2) CSB-YP717316BNS
CSB-EP717316BNS
CSB-BP717316BNS
CSB-MP717316BNS
CSB-EP717316BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP717317BNS
CSB-EP717317BNS
CSB-BP717317BNS
CSB-MP717317BNS
CSB-EP717317BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Putative iron-sulfur cluster insertion protein ErpA (erpA) CSB-YP717318BNS
CSB-EP717318BNS
CSB-BP717318BNS
CSB-MP717318BNS
CSB-EP717318BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Glutamate-ammonia-ligase adenylyltransferase (glnE), partial CSB-YP717319BNS
CSB-EP717319BNS
CSB-BP717319BNS
CSB-MP717319BNS
CSB-EP717319BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Quinolinate synthase A (nadA) CSB-YP717320BNS
CSB-EP717320BNS
CSB-BP717320BNS
CSB-MP717320BNS
CSB-EP717320BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Urease subunit alpha (ureC), partial CSB-YP717321BNS
CSB-EP717321BNS
CSB-BP717321BNS
CSB-MP717321BNS
CSB-EP717321BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP717322BNS
CSB-EP717322BNS
CSB-BP717322BNS
CSB-MP717322BNS
CSB-EP717322BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei UPF0226 membrane protein BMA2043 (BMA2043), partial CSB-YP717323BNS
CSB-EP717323BNS
CSB-BP717323BNS
CSB-MP717323BNS
CSB-EP717323BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Maf-like protein BMA1890 (BMA1890) CSB-YP717324BNS
CSB-EP717324BNS
CSB-BP717324BNS
CSB-MP717324BNS
CSB-EP717324BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Uracil phosphoribosyltransferase (upp) CSB-YP717325BNS
CSB-EP717325BNS
CSB-BP717325BNS
CSB-MP717325BNS
CSB-EP717325BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit B 1 (nuoB1) CSB-YP717326BNS
CSB-EP717326BNS
CSB-BP717326BNS
CSB-MP717326BNS
CSB-EP717326BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Lysine--tRNA ligase (lysS), partial CSB-YP717327BNS
CSB-EP717327BNS
CSB-BP717327BNS
CSB-MP717327BNS
CSB-EP717327BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP717328BNS
CSB-EP717328BNS
CSB-BP717328BNS
CSB-MP717328BNS
CSB-EP717328BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>